RAM
BMRN icon

Resona Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Resona Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Hold
20,696
– – 0.01% 627
2025
Q4 		$1.23M Sell
20,696
-56,136
-73% -$3.06M 0.01% 626
2025
Q3 		$4.16M Sell
76,832
-4,227
-5% -$242K 0.02% 525
2025
Q2 		$4.46M Buy
81,059
+3,795
+5% +$223K 0.02% 521
2025
Q1 		$5.47M Buy
77,264
+3,784
+5% +$255K 0.03% 440
2024
Q4 		$4.84M Sell
73,480
-4,283
-6% -$287K 0.03% 468
2024
Q3 		$5.47M Buy
77,763
+1,231
+2% +$103K 0.03% 458
2024
Q2 		$6.31M Sell
76,532
-3,697
-5% -$308K 0.04% 393
2024
Q1 		$7.01M Buy
+80,229
New +$7.18M 0.04% 380

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return